A Self-Administered Home Flu Vaccine Is Coming—8 Things to Know About It
Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
What Doctors Want You to Know About the New Home Flu Vaccine Coming Next Year
Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
FDA just greenlighted an at-home flu vaccine. What the approval of a self-administered spray means for you.
FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.
Pharmaceutical Technology15h
FDA approves AstraZeneca FluMist flu vaccine for self-administration
The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
ConsumerAffairs15h
FDA approves first at-home nasal spray flu vaccine for the 2-49 age range
The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
You can get an at-home flu ‘shot’ starting next year
The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...
FDA approves at-home flu vaccine nasal spray. Here's what to know about it.
AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...
When should you get the flu shot? A doctor weighs in on best timing, options.
What to know about the "optimal time" to get vaccinated against the flu — and how the FluMist nasal spray stacks up to the traditional shot.
Pharmaceutical Technology2h
EMA CHMP recommends AstraZeneca’s Fasenra to treat EGPA
The EMA CHMP has recommended granting approval for AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis ...
CNET on MSN15h
An At-Home Flu Vaccine? It'll Be Available Next Year
The vaccine, called FluMist, is a nasal vaccine that's been available since 2003 but given in-clinic by a healthcare provider ...
The American Journal of Managed Care18h
FDA Approves First Self-Administered Nasal Spray Flu Vaccine
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...
healthcarepackaging19h
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration
· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...